Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

September 16, 2020

Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease

Journal of Neurology, Neurosurgery, and Psychiatry
Samir Abu-RumeilehPiero Parchi
September 16, 2020

What Happened in the Hippocampal Axon in a Rat Model of Posttraumatic Stress Disorder

Cellular and Molecular Neurobiology
Yadi GuanFang Han
September 16, 2020
Review
Open Access

Microtubule Dynamics and Neuronal Excitability: Advances on Cytoskeletal Components Implicated in Epileptic Phenomena

Cellular and Molecular Neurobiology
Giuditta GambinoPierangelo Sardo
September 14, 2020

Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology

Biological Psychiatry
Tengfei GuoAlzheimer’s Disease Neuroimaging Initiative
September 15, 2020

Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Adam O GhoweriOlivier Thibault
September 15, 2020

Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Shubir DuttAlzheimer’s Disease Neuroimaging Initiative
September 16, 2020
Open Access

Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice

International Journal of Molecular Sciences
Alejandro R RodaSandra Villegas
September 15, 2020
Review
Open Access

The complex relationship between genotype, pathology and phenotype in familial dementia

Neurobiology of Disease
John B KwokGlenda M Halliday
September 15, 2020
Open Access

Wheel-Running Behavior Is Negatively Impacted by Zinc Administration in a Novel Dual Transgenic Mouse Model of AD

Frontiers in Neuroscience
Stephen L P LippiJane M Flinn
September 15, 2020

Neuro-Retina Might Reflect Alzheimer's Disease Stage

Journal of Alzheimer's Disease : JAD
Roberto SantangeloLetizia Leocani
September 15, 2020

Novel Amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity

Progress in Neurobiology
Christian GallreinJanine Kirstein
September 15, 2020

Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders

Journal of Alzheimer's Disease : JAD
Matthew John MoldChristopher Exley
September 16, 2020
Open Access

Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder

Nature Communications
Gabor EgervariYasmin L Hurd
September 15, 2020

Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Isabel J SibleAlzheimer’s Disease Neuroimaging Initiative

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tau-aggregation-genomics/dd022db5-6b6e-48b7-a623-82e481dc12ef